Comparative Effects of Nesiritide and Nitroglycerin on Renal Function, and Incidence of Renal Injury by Traditional and RIFLE Criteria in Acute Heart Failure

被引:10
作者
Ng, Tien M. H. [1 ]
Ackerbauer, Kimberly A. [1 ]
Hyderi, Alifiya F. [1 ]
Hshieh, Shenche [1 ]
Elkayam, Uri [2 ]
机构
[1] Univ So Calif, Sch Pharm, Los Angeles, CA 90033 USA
[2] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA
关键词
acute heart failure; nesiritide; nitroglycerin; acute kidney injury; RIFLE criteria; BRAIN NATRIURETIC PEPTIDE; LOW-DOSE NESIRITIDE; INTRAVENOUS NESIRITIDE; DYSFUNCTION; OUTCOMES; TRIAL; THERAPY; SURGERY; RISK;
D O I
10.1177/1074248411406441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Acute renal insufficiency is associated with poorer outcomes in heart failure. Data regarding the renal effects of vasodilatory therapy in acute heart failure are inconclusive. Hypothesis: Nesiritide and nitroglycerin are associated with differing effects on the incidence of acute renal injury and glomerular filtration rate changes. Methods: A retrospective cohort study of patients hospitalized with acute congestive heart failure who received intravenous nesiritide or nitroglycerin for >= 6 hours. Acute kidney injury was assessed by risk, injury, failure, loss, and end stage (RIFLE) classification (creatinine/GFR criteria) and by traditional acute rise in creatinine of 0.3 mg/dL or 25%. Secondary endpoints included change in estimated glomerular filtration rate, serum creatinine, serum blood urea nitrogen, blood pressure, and urine output. Results: A total of one hundred and thirty-one patients (age 57 +/- 12 years, 67% male, left ventricular ejection fraction 38 +/- 35%, 30% ischemic) received nesiritide (N = 37) or nitroglycerin (N = 94). Diuretic regimen and doses were similar in both the groups. Mean duration of therapy was not different (nesiritide 38.6 +/- 35.7 h vs nitroglycerin 30.7 +/- 22.6 h, P = .13). No differences were detected in incidence of renal injury using either criteria (RIFLE: nesiritide 19% vs nitroglycerin 22%, P = .88; traditional: 22% vs 34%, P = .16); however, glomerular filtration rate declined (-1 +/- 18 mL/min vs -9 +/- 21 mL/min, P = .03) and blood urea nitrogen increased (-0.2 +/- 9.9 mg/dL vs 4.2 +/- 9.1 mg/dL, P = .02) to a greater degree with nitroglycerin. Nesiritide was associated with lower hourly blood pressures and a higher incidence of systolic blood pressure <80 mm Hg. Conclusion: The incidence of renal injury was not different between nesiritide-and nitroglycerin-treated patients with acute heart failure; however, nitroglycerin was associated with a decline in glomerular filtration rate and increase in blood urea nitrogen despite higher baseline and on treatment blood pressures.
引用
收藏
页码:79 / 85
页数:7
相关论文
共 21 条
  • [1] ABRAHAM WT, 2005, CIRCULATION, V112, P589
  • [2] Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group
    Bellomo, R
    Ronco, C
    Kellum, JA
    Mehta, RL
    Palevsky, P
    [J]. CRITICAL CARE, 2004, 8 (04): : R204 - R212
  • [3] Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure
    Cataliotti, A
    Boerrigter, G
    Costello-Boerrigter, LC
    Schirger, JA
    Tsuruda, T
    Heublein, DM
    Chen, HH
    Malatino, LS
    Burnett, JC
    [J]. CIRCULATION, 2004, 109 (13) : 1680 - 1685
  • [4] Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery - A double-blind placebo-controlled pilot study
    Chen, Horng H.
    Sundt, Thoralf M.
    Cook, David J.
    Heublein, Denise M.
    Burnett, John C., Jr.
    [J]. CIRCULATION, 2007, 116 (11) : I134 - I138
  • [5] ACUTE VASODILATOR THERAPY INCREASES RENAL CLEARANCE OF DIGOXIN IN PATIENTS WITH CONGESTIVE HEART-FAILURE
    COGAN, JJ
    HUMPHREYS, MH
    CARLSON, CJ
    BENOWITZ, NL
    RAPAPORT, E
    [J]. CIRCULATION, 1981, 64 (05) : 973 - 976
  • [6] Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure.
    Colucci, WS
    Elkayam, U
    Horton, DP
    Abraham, WT
    Bourge, RC
    Johnson, AD
    Wagoner, LE
    Givertz, MM
    Liang, CS
    Neibaur, M
    Haught, WH
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (04) : 246 - 253
  • [7] Assessment of Renal Hemodynamic Effects of Nesiritide in Patients With Heart Failure Using Intravascular Doppler and Quantitative Angiography
    Elkayam, Uri
    Akhter, Mohamed W.
    Liu, Ming
    Hatamizadeh, Parta
    Barakat, Mohamad N.
    [J]. JACC-CARDIOVASCULAR IMAGING, 2008, 1 (06) : 765 - 771
  • [8] Risk stratification for in-hospital mortality in acutely decompensated heart failure - Classification and regression tree analysis
    Fonarow, GC
    Adams, KF
    Abraham, WT
    Yancy, CW
    Boscardin, WJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (05): : 572 - 580
  • [9] The Significance of Serum Urea and Renal Function in Patients With Heart Failure
    Gotsman, Israel
    Zwas, Donna
    Planer, David
    Admon, Dan
    Lotan, Chaim
    Keren, Andre
    [J]. MEDICINE, 2010, 89 (04) : 197 - 203
  • [10] Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population
    Hata, Noritake
    Yokoyama, Shinya
    Shinada, Takuro
    Kobayashi, Nobuaki
    Shirakabe, Akihiro
    Tomita, Kazunori
    Kitamura, Mitsunobu
    Kurihara, Osamu
    Takahashi, Yasuhiro
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2010, 12 (01) : 32 - 37